Interferon α may be used as a single agent therapy for metastatic malignant melanoma or as an adjuvant to chemotherapy. Delivery of interferon α by gene therapy offers an alternative to recombinant protein therapy. Electrically mediated delivery enhances plasmid expression in a number of tissues, for instance skin, liver, muscle and tumors including melanomas. Here we compare the effect of delivery of a plasmid encoding mouse interferon α on growth of visible B16 mouse melanomas following electrically mediated delivery to muscle or directly to the tumor. Intratumoral delivery of interferon α plasmid not only slows melanoma growth, but induces complete, long term, regression. This effect was not observed after intramuscular delivery.
References
1.
LeghaS. S.The Role of Interferon Alfa in the Treatment of Metastatic Melanoma, Semin. Oncol.24, S4-24–S4-31 (1997).
2.
AgarwalaS. S. and KirkwoodJ. M.Adjuvant Therapy of Melanoma, Semin. Surg. Oncol.14, 302–310 (1998).
3.
FleischmannC. M., StantonG. J., and FleischmannW. R.Jr.. Enhanced in vivo Sensitivity to Interferon with in vitro Resistant B16 Tumor Cells in Mice, Cancer Immunol. Immunother.39, 148–154 (1994).
4.
WuT. Y. and FleischmannW. R.Jr.. Efficacy of B16 Melanoma Cells Exposed in vitro to Long-Term IFN-α Treatment (B16α Cells) as a Tumor Vaccine in Mice, J. Interferon Cytokine Res.18, 829–839 (1998).
5.
KaidoT., BanduM.-T., MauryC., FerrantiniM., BelardelliF, and GresserI.IFN-α1 Gene Transfection Completely Abolishes the Tumorigenicity of Murine B16 Melanoma Cells in Allogeneic DBA/2 Mice and Decreases Their Tumorigenicity in Syngeneic C57BL/6 Mice, Int. J. Cancer60, 221–229 (1995).
6.
JaroszeskiM. J., GilbertR., HellerR.Electrochemotherapy: An emerging drug delivery method for the treatment of cancer, Adv. Drug Del. Rev.26, 185–197 (1997).
7.
HellerR., GilbertR., JaroszeskiM.Clinical applications of electrochemotherapy, Adv. Drug Del. Rev.35, 119–129 (1999).
8.
SomiariS., Glasspool-MaloneJ., DrabickJ. J., GilbertR. A., HellerR., JaroszeskiM. J., and MaloneR. W.Theory and in vivo application of electroporative gene delivery, Mol. Ther.2, 178–187 (2000).
9.
HellerL. C. and LucasM. L.Delivery of plasmid DNA by in vivo electroporation, Gene Ther. and Mol. Biol.5, 50–55 (2000).
10.
TitomirovA. V., SukharevS, KistanovaE.In vivo electroporation and stable transformation of newborn mice by plasmid DNA, Biochim. Biophys. Acta1088, 131–134 (1991).
HellerR., SchultzJ., LucasM. L., JaroszeskiM. J., HellerL. C., GilbertR. A., MoellingK., and NicolauC.Intradermal delivery of IL-12 plasmid DNA by in vivo electroporation, DNA and Cell Biol20, 21–26 (2001).
13.
HellerR, JaroszeskiM., AtkinA., MoradpourD., GilbertR., WandsJ., and NicolauC.In vivo gene electroinjection and expression in rat liver, FEBS Lett389, 225–228 (1996).
14.
AiharaH., MiyazakiJ.-I.Gene transfer into muscle by electroporation in vivo, Nat Biotech6, 867–870 (1998).
15.
MirL. M., BureauM. F., GehlJ., RangaraR., RouyD., CaillaudJ.-M., DelaereP., BranellecD., SchwartzB., and SchermanD.High-efficiency gene transfer into skeletal muscle mediated by electric pulses, Proc. Natl. Acad. Sci., USA96, 4262–4267 (1999).
16.
MathiesenI.Electropermeabilization of skeletal muscle enhances gene transfer in vivo, Gene Ther.6, 508–514 (1999).
17.
VicatJ. M., BoisseauS., JourdesP., LaineM., WionD., Bouali-BenazzouzR., BenabidA. L., and BergerF.Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression, Hum. Gene Ther.11, 11: 909–916 (2000).
18.
MaruyamaH., SugawaM., MoriguchiY., ImazekiI., IshikawaY., AtakaK., HasegawaS., ItoY., HiguchiN., KazamaJ. J., GejyoF., and MiyazakiJ.-I.Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation, Hum. Gene Ther.11, 429–437 (2000).
19.
WideraG., AustinM., RabussayD., GoldbeckC., BarnettS. W., ChenM., LeungL., OttenG. R., ThudiumK., SelbyM. J., and UlmerJ. B.Increased DNA vaccine delivery and immunogenicity by electroporation in vivo, J. Immuno.164, 4635–4640 (2000).
20.
LiS., ZhangX., XiaX., ZhouL., BreauR., SuenJ., and HannaE.Intramuscular electroporation delivery of IFN-α Gene Therapy for Inhibition of Tumor Growth Located at a Distant Site, Gene Ther.8, 400–407 (2001).
21.
NishiT., YoshizatoK., YamashiroS., TakeshimaH., SatoK., HamadaK., KitamuraI., YoshimuraT., SayaH., KuratsuJ., and UshioY.High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation, Cancer Res.56, 1050–1055 (1996).
22.
RolsM.-P., DelteilC., GolzioM., DumondP., CrosS., and TeissieJ.In vivo electrically mediated protein and gene transfer in murine melanoma, Nat. Biotech.16, 168–171 (1998).
23.
HellerL., JaroszeskiM. J., CoppolaD., PottingerC., GilbertR., and HellerR.Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo, Gene Ther.7, 826–829 (2000).
24.
NiuG., HellerR., Catlett-FalconeR., CoppolaD., JaroszeskiM., DaltonW., JoveR., and YuH.Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo, Cancer Res.59, 5059–5063 (1999).
25.
LohrF., LoD. Y., ZaharoffD. A., HuK., ZhangX., LiY., ZhaoY., DewhirstM. W., YuanF., and LiC. Y.Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation, Cancer Res.61, 3281–3284 (2001).
26.
KishidaT., AsadaH., SatohE., TanakaS., ShinyaM., HiraiH., IwaiM., TaharaH., ImunishiJ., and MazdaO.In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice, Gene Ther.8, 1234–1240 (2001).
27.
HellerL. C., PottingerC., JaroszeskiM. J., GilbertR., and HellerR.In vivo electroporation of plasmids encoding GMCSF and interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long term antitumor immunity, Melanoma Res.10, 577–583 (2000).
28.
HortonH. M., AndersonD., HernandezP., BarnhartK. M., NormanJ. A., and ParkerS. E.A Gene Therapy for Cancer using Intramuscular Injection of Plasmid DNA Encoding Interferon α, Proc. Natl. Acad. Sci. USA96, 1553–158 (1999).
29.
GilbertR., JaroszeskiM. J., and HellerR.Novel electrode designs for electrochemotherapy, Biochim. Biophys. Acta1334, 9–14 (1997).
30.
LucasM. L. and HellerR.Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle, Mol. Ther.3, 47–53 (2001).
